HK$ 1.75 billion
Completed
12/11/2019
Adam Majeed - Asia editor
Hong Kong SAR
IPO
Capital markets : Equity
Pharmaceuticals and life sciences
Party: China International Capital Corporation Hong Kong Securities (Joint sponsor, Joint global coordinator, Joint lead manager, Joint bookrunner)
Party: Orient Securities (Joint global coordinator, Joint bookrunner, Joint lead manager)
Party: China Everbright Securities Ltd (Joint bookrunner, Joint lead manager)
Party: Guotai Junan Securities (Joint bookrunner, Joint lead manager)
Party: CMB International Capital (Joint bookrunner, Joint lead manager)
Party: Haitong International Securities Group Ltd (Joint bookrunner, Joint lead manager)
Party: Fosun Hani Securities (Joint bookrunner, Joint lead manager)
Party: Orient Capital (Joint sponsor)
Party: Victory Securities Company (Joint bookrunner, Joint lead manager)
Party: China International Capital Corporation Hong Kong Securities (Joint sponsor, Joint global coordinator, Joint bookrunner, Joint lead manager)
Party: Orient Securities (Joint global coordinator, Joint bookrunner, Joint lead manager)
Party: China Everbright Securities Ltd (Joint bookrunner, Joint lead manager)
Party: Guotai Junan Securities (Joint bookrunner, Joint lead manager)
Party: CMB International Capital (Joint bookrunner, Joint lead manager)
Party: Haitong International Securities Group Ltd (Joint bookrunner, Joint lead manager)
Party: Fosun Hani Securities (Joint bookrunner, Joint lead manager)
Party: Orient Capital (Joint sponsor)
Party: Victory Securities Company (Joint bookrunner, Joint lead manager)
Party: SinoMab BioScience (Issuer)